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A 63-year-old male presented with progressive
right-sided hemiparesis, facial palsy, and aphasia.
He had been scheduled for neoadjuvant chemo-
therapy for relapsing adenocarcinoma of the left
colic flexure, and a left-sided port-a-cath was
implanted 7 days ago. The CCT scan revealed
several already well-demarked ischaemic brain
lesions. Treatment with aspirin and statin was
initiated.
Chest X-ray revealed an unusual left-sided
downward course of the port-a-cath catheter
to the left atrium. Injection of agitated saline
into the left cubital vein showed microbubbles
in the left atrium (Panel A). In contrast, injection
into the right arm resulted in opacification of the
right atrium (Panel B). TEE demonstrated an iso-
lated left-sided superior vena cava draining into
the left atrium between the left atrial appendage
and the left upper pulmonary vein (Panel C). The
innominate vein was absent, while there was
normal course of the right superior vena cava.
Except for a very small left ventricular diverticu-
lum, cardiac anatomy was otherwise normal.
Retrospective analysis of a former thoracic CT
scan (Panel D) and MR angiography (Panel E)
confirmed the persistent left superior vena
cava (PLSVC). To our knowledge, there has not been described yet an isolated defect of LSVC draining into the left atrium as
single anomaly without atresia of coronary sinus, any septal defects and any valvular abnormalities.
PLSVC draining to the left atrium is clinically relevant as it predisposes to paradoxical embolism, particularly in the context
of venous injections into the left arm, device implantation, or central vein cannulation from the left side.
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